Shukla Sanjay 4
4 · aTYR PHARMA INC · Filed Dec 12, 2023
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2023-12-12$1.18/sh+12,000$14,136→ 106,173 total - Purchase
Common Stock
2023-12-11$1.17/sh+3,000$3,510→ 94,173 total
Footnotes (1)
- [F1]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.175 to $1.18 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.